Sanofi to Buy Vigil Neuroscience for About $470 Million
In This Article:
Sanofi has entered an agreement to acquire Vigil Neuroscience for approximately $470 million, adding a new investigational treatment for Alzheimer’s disease to the French pharmaceutical company’s pipeline.